WHO ICTRP trial

Aftogel and COVID-19 PCR test

IRCT20181208041886N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20181208041886N2
Public title Aftogel and COVID-19 PCR test
Scientific title The effect of Aftogel strips on results of nasopharyngeal secretion PCR test in volunteers with positive test for COVID-19 virus
Primary sponsor Exir Danesh Asia Pharmaceutical company
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions COVID-19. U07.1 COVID-19, virus identified•U07.2 COVID-19, virus not identifiedoClinically-epidemiologically diagnosed COVID-19oProbable COVID-19 oSuspected COVID-19;U07.1COVID
Interventions Intervention 1: Intervention group: the patients with positive COVID-19 Rt PCR test will be selected and on random manner they will be treated with tentative drug (Aftogel strip) . This drug is made by Exir Danesh Asia pharmaceutical…
Registration date Oct 29, 2020
Target size 60
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations